Veraxa Biotech AG (VRXA)
NASDAQ
VRXA price, last 12 months
Key stats
- Previous close
- $1.03
- Open
- $1.05
- Day range
- $1.03 – $1.09
- 52-week range
- $0.9000 – $27.36
- Volume
- 115.9K
- Avg volume (20 days)
- 156K
- Market cap
- $157.0M
Performance
Technicals and fundamentals
About Veraxa Biotech AG
Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.
- Listed on
- NASDAQ
- Market cap
- $157.0M